We propose gene expression profiling for the characterization of innate immunity and adaptive immunity pertinent to solid organ transplantation. We also propose interventional trials that will address critical unmet needs;the clinical studies are underpinned by mechanistic studies. Our proposals were stimulated by our single center studies and evolving literature that mRNA profiling of peripheral blood cells, urinary cells, and bronchoalveolar lavage (BAL) cells are diagnostic of allograft status. Our identification of mRNA profiles of intraoperative renal allograft biopsy specimens that predict acute rejection and renal allograft functional outcome has informed our research design. We propose cooperative multi-site kidney-specific and multi-organ studies to determine whether there is common molecular profile characteristic of inflammatory and immune responses, and which can provide a better method to monitor function and apply interventional modalities aimed at improving graft outcome. In renal allograft recipients, we will investigate whether: (a) acute rejection can be predicted by sequential mRNA profiling of urinary cells;(b) preemptive treatment, based on mRNA profiles, prevents acute rejection and preserves GFR, and (c) mRNA profiles can be used to guide immunosuppression management, such as the withdrawal of calcineurin inhibitors in stable recipients. Studies in diverse groups of transplanted organs will center on the molecular profiling of organ specific and nonspecific injury pathways in the donor prior to procurement and in the recipient immediately after transplantation, and their impact on organ function and alloreactivity. More focused studies will be done in the lung and the liver setting. In lung allografts, we will explore: (a) whether mRNA profiling of cells obtained by donor and recipient BAL cells predict adverse outcomes such as intense inflammation and development of impaired graft function, (b) whether a persistent inflammatory signature of BAL cells is followed by an acute rejection signature. In liver allografts, we will explore: (a) whether an early inflammatory response indicated by a unique mRNA profile of proinflammatory genes is correlated with HCV recurrence, and (b) whether a steroid-avoidance protocol downregulates HCV recurrence in grafts expressing intense inflammatory signature. These mechanistic assays will be carried out with the use of kinetic (real) time quantitative PCR assay, and in select instances with the use of nucleic-acid based microarrays, as well as immunohistologic analysis of the site of gene expression, and are expected to yield data that will be applied in routine clinical care of the transplanted population.
Diamond, J M; Cantu, E; Porteous, M K et al. (2017) Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation. Am J Transplant 17:1770-1777 |
Suhre, Karsten; Schwartz, Joseph E; Sharma, Vijay K et al. (2016) Urine Metabolite Profiles Predictive of Human Kidney Allograft Status. J Am Soc Nephrol 27:626-36 |
Li, Yun R; van Setten, Jessica; Verma, Shefali S et al. (2015) Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studies. Genome Med 7:90 |
International Genetics & Translational Research in Transplantation Network (iGeneTRAiN) (2015) Design and Implementation of the International Genetics and Translational Research in Transplantation Network. Transplantation 99:2401-12 |
Wolf, Joshua H; Bhatti, Tricia R; Fouraschen, Suomi et al. (2014) Heat shock protein 70 is required for optimal liver regeneration after partial hepatectomy in mice. Liver Transpl 20:376-85 |
Lee, John R; Muthukumar, Thangamani; Dadhania, Darshana et al. (2014) Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol Rev 258:218-40 |
Suzuki, Yoshikazu; Cantu, Edward; Christie, Jason D (2013) Primary graft dysfunction. Semin Respir Crit Care Med 34:305-319 |
Cantu, E; Lederer, D J; Meyer, K et al. (2013) Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation. Am J Transplant 13:1898-904 |
Suthanthiran, Manikkam; Schwartz, Joseph E; Ding, Ruchuang et al. (2013) Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med 369:20-31 |
Friedman, Benjamin H; Wolf, Joshua H; Wang, Liqing et al. (2012) Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transpl 18:166-76 |
Showing the most recent 10 out of 13 publications